Author
Yaoxing Huang
Aaron Diamond AIDS Research CenterORCID 0000-0001-6270-1644Unclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2024-2026 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 45 mutual co-author links5 papers
Recent·Most cited
- MicrobiologybioRxivPreprint
A Monoclonal Antibody Panel to Track Antigenic Evolution of SARS-CoV-2 JN.1 Subvariants
Hsiang Hong, Madeline Wu, Sue Chong…·David D. Ho
The paper develops a monoclonal antibody panel to track antigenic evolution of SARS-CoV-2 JN.1 subvariants and identifies differences in antibody-evasion profiles between JN.1 and BA.3.2 lineages.
1 citation - MicrobiologybioRxivPreprint
A Panel of Human Monoclonal Antibodies for Tracking the Antigenic Evolution of Influenza H5N1 Clade 2.3.4.4b
Hsiang Hong, Nicholas C. Morano, Madeline Wu…·David D. Ho
This study generates 19 human monoclonal antibodies to track antigenic evolution of H5N1 clade 2.3.4.4b, identifying epitope-specific neutralization patterns and antigenic differences between viral genotypes.
2 citations - MicrobiologyNature CommunicationsPeer-reviewed
Optimizing a Human Monoclonal Antibody for Better Neutralization of SARS-CoV-2
Qian Wang, Yicheng Guo, Ryan G. Casner…·David D. Ho
This study optimizes a human monoclonal antibody to enhance its neutralization of SARS-CoV-2 variants, including subvariants XEC and LP.8.1, through structural analysis and engineering.
15 citationstop 1% - MicrobiologyThe Journal of Infectious DiseasesPeer-reviewed
Persistence of an infectious form of SARS-CoV-2 post protease inhibitor treatment of permissive cells in vitro
Manoj S. Nair, Maria I. Luck, Yaoxing Huang…·David D. Ho
The paper shows that an infectious intermediate form of SARS-CoV-2 persists in vitro after protease inhibitor treatment, potentially explaining viral rebound in patients.